公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2009 | Advances in the diagnosis of gestational trophoblastic tumors and tumor-like lesions | TSUI-LIEN MAO ; Shih I.-M. | Expert Opinion on Medical Diagnostics | 3 | 0 | |
2009 | Analysis of DNA copy number alterations in Ovarian serous tumors identifies new molecular genetic changes in low-grade and high-grade carcinomas | KUAN-TING KUO ; Guan B.; Feng Y.; TSUI-LIEN MAO ; Chen X.; Jinawath N.; Wang Y.; Kurman R.J.; Shih I.-M.; Wang T.-L. | Cancer Research | 153 | 126 | |
2009 | Analysis of DNA copy number alterations in ovarian serous tumors identifies new molecular genetic changes in low-grade and high-grade carcinomas (Cancer Research (2009) 69, (4036-42)) | KUAN-TING KUO ; Guan B.; Feng Y.; TSUI-LIEN MAO ; Chen X.; Jinawath N.; Wang Y.; Kurman R.J.; Shih I.-M.; Wang T.-L. | Cancer Research | 1 | 0 | |
2017 | CCNE1 copy-number gain and overexpression identify ovarian clear cell carcinoma with a poor prognosis | Ayhan A.; Kuhn E.; Wu R.-C.; Ogawa H.; Bahadirli-Talbott A.; TSUI-LIEN MAO ; Sugimura H.; Shih I.-M.; Wang T.-L. | Modern Pathology | 41 | 40 | |
2010 | Clinicopathological significance of loss of ARID1A immunoreactivity in ovarian clear cell carcinoma | Maeda D.; TSUI-LIEN MAO ; Fukayama M.; Nakagawa S.; Yano T.; Taketani Y.; Shih I.-M. | International Journal of Molecular Sciences | 87 | 89 | |
2006 | Cyclin E and p16 immunoreactivity in epithelioid trophoblastic tumor - An aid in differential diagnosis | TSUI-LIEN MAO ; Seidman J.D.; Kurman R.J.; Shih I.-M. | American Journal of Surgical Pathology | 74 | 65 | |
2009 | Cystic and adenofibromatous clear cell carcinomas of the ovary: Distinctive tumors that differ in their pathogenesis and behavior: A clinicopathologic analysis of 122 cases | Veras E.; TSUI-LIEN MAO ; Ayhan A.; Ueda S.; Lai H.; Hayran M.; Shih I.-M.; Kurman R.J. | American Journal of Surgical Pathology | 108 | 92 | |
2010 | DNA copy numbers profiles in affinity-purified ovarian clear cell carcinoma | KUAN-TING KUO ; TSUI-LIEN MAO ; Chen X.; Feng Y.; Nakayama K.; Wang Y.; Glas R.; Ma M.J.; Kurman R.J.; Shih I.-M.; Wang T.-L. | Clinical Cancer Research | 72 | 77 | |
2012 | Endocervical-type mucinous borderline tumors are related to endometrioid tumors based on mutation and loss of expression of ARID1A | Wu C.H.; TSUI-LIEN MAO ; Vang R.; Ayhan A.; Wang T.-L.; Kurman R.J.; Shih I.-M. | International Journal of Gynecological Pathology | 67 | 52 | |
2006 | Expression of Rsf-1, a chromatin-remodeling gene, in ovarian and breast carcinoma | TSUI-LIEN MAO ; Hsu C.-Y.; Yen M.J.; Gilks B.; Sheu J.J.-C.; Gabrielson E.; Vang R.; Cope L.; Kurman R.J.; Wang T.-L.; Shih I.-M. | Human Pathology | 34 | 33 | |
2009 | Frequent activating mutations of PIK3CA in ovarian clear cell carcinoma | KUAN-TING KUO ; TSUI-LIEN MAO ; Jones S.; Veras E.; Ayhan A.; Wang T.-L.; Glas R.; Slamon D.; Velculescu V.E.; Kuman R.J.; Shih I.-M. | American Journal of Pathology | 382 | 339 | |
2010 | Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma | Jones S.; Wang T.-L.; Shih I.-M.; TSUI-LIEN MAO ; Nakayama K.; Roden R.; Glas R.; Slamon D.; Diaz Jr. L.A.; Vogelstein B.; Kinzler K.W.; Velculescu V.E.; Papadopoulos N. | Science | 1029 | 938 | |
2007 | Generation and characterization of an ascitogenic mesothelin-expressing tumor model | WEN-FANG CHENG ; Hung C.-F.; Chai C.-Y.; CHI-AN CHEN ; CHIEN-NAN LEE ; Su Y.-N.; WEN-YIH TSENG ; CHANG-YAO HSIEH ; Shih I.-M.; Wang T.-L.; Wu T.-C. | Cancer | 20 | 20 | |
2008 | HSD3B1 as a novel trophoblast-associated marker that assists in the differential diagnosis of trophoblastic tumors and tumorlike lesions | TSUI-LIEN MAO ; Kurman R.J.; YUNG-MING JENG ; Huang W.; Shih I.-M. | American Journal of Surgical Pathology | 44 | 34 | |
2012 | Identification of molecular pathway aberrations in uterine serous carcinoma by genome-wide analyses | Kuhn E.; Wu R.-C.; Guan B.; Wu G.; Zhang J.; Wang Y.; Song L.; Yuan X.; Wei L.; Roden R.B.S.; KUAN-TING KUO ; Nakayama K.; Clarke B.; Shaw P.; Olvera N.; Kurman R.J.; Levine D.A.; Wang T.-L.; Shih I.-M. | Journal of the National Cancer Institute | 206 | 186 | |
2009 | IGF2BP3 (IMP3) expression is a marker of unfavorable prognosis in ovarian carcinoma of clear cell subtype | Köbel M.; Xu H.; Bourne P.A.; Spaulding B.O.; Shih I.-M.; TSUI-LIEN MAO ; Soslow R.A.; Ewanowich C.A.; Kalloger S.E.; Mehl E.; Lee C.-H.; Huntsman D.; Gilks C.B. | Modern Pathology | 112 | 106 | |
2007 | Immunohistochemistry of choriocarcinoma: An aid in differential diagnosis and in elucidating pathogenesis | TSUI-LIEN MAO ; Kurman R.J.; Huang C.-C.; Lin M.-C.; Shih I.-M. | American Journal of Surgical Pathology | 77 | 61 | |
2015 | Increased proliferation in atypical hyperplasia/endometrioid intraepithelial neoplasia of the endometrium with concurrent inactivation of ARID1A and PTEN tumour suppressors | Ayhan A.; TSUI-LIEN MAO ; Suryo Rahmanto Y.; Zeppernick F.; Ogawa H.; Wu R.-C.; Wang T.-L.; Shih I.-M. | Journal of Pathology: Clinical Research | 31 | 0 | |
2015 | Inhibition of Spleen Tyrosine Kinase Potentiates Paclitaxel-Induced Cytotoxicity in Ovarian Cancer Cells by Stabilizing Microtubules | Yu Y.; Gaillard S.; Phillip J.; TAI-CHUNG HUANG ; Pinto S.; Tessarollo N.; Zhang Z.; Pandey A.; Wirtz D.; Ayhan A.; Davidson B.; Wang T.-L.; Shih I.-M. | Cancer Cell | 101 | 100 | |
2010 | Lack of a Y-chromosomal complement in the majority of gestational trophoblastic neoplasms | Yap K.L.; Hafez M.J.; TSUI-LIEN MAO ; Kurman R.J.; Murphy K.M.; Shih I.-M. | Journal of Oncology | 12 | 0 |